Skip to main content
. Author manuscript; available in PMC: 2009 Nov 15.
Published in final edited form as: Cancer Res. 2008 Nov 15;68(22):9107–9111. doi: 10.1158/0008-5472.CAN-08-2556

Figure 1.

Figure 1

The TGFβ ligands signal through the type I and type II TGFβ receptors. Canonical signaling proceeds with phosphorylation of Smad2 and Smad3, which then combine with Smad4 to enter the nucleus to mediate growth inhibition. Smad7 is a negative mediator in this process. In addition, TGFβ binding to its receptors activates many noncanonical signaling pathways and regulates tumor cell migration and metastasis.